“…Although drug treatments tackling CRHR1 have been envisioned as potentially promising anxiolytic and antidepressive drugs (Kunzel et al, 2003;Refojo and Holsboer, 2009), recent evidence in rodents suggests that they could also be effective in modifying not only actual pathological manifestations at adulthood but also the developmental trajectories linking early adversity to adult psychopathology. These rodent studies showed that exposure to stress during the two first postnatal weeks leads to increased central CRH and CRHR1 expression, and altered a number of behaviors in tests of emotion and cognition (Plotsky et al, 2005;Ivy et al, 2010;Wang et al, 2011Wang et al, , 2012. Importantly, they also found that some of the long-term behavioral alterations could be reversed by inhibiting CRHR1 function (e.g., through CRHR1 antagonist treatment or conditional forebrain CRHR1 knockout) in the developmental period occurring immediately after early life stress (Ivy et al, 2010;Wang et al, 2011Wang et al, , 2012.…”